Ingredient name record

Adenosine

Korean search label: 아데노신

Evidence at a glance

1official function labelsIngredient context 1selected human studiesNot a full review

0selected legal receiptsNot a compliance verdict

359product recordsRecorded occurrences

Evidence coverage, not an efficacy or safety score.

Identity & coverage details

Official CosIng inventory context recorded; chemical identity and the complete current regulatory profile remain unverified; selected human studies available.

Recorded presence is not a safety rating, recommended dose or benefit claim.

Identity and formulation context

Names are indexed using case and whitespace normalization. Botanical, chemical and marketing identities have not been independently equated.

This trial tested an adenosine cream and dissolvable film. Delivery format and unknown concentration limit transfer to another serum, cream or patch.

Discovery spellings and aliases

adenosine · 아데노신 · 아데노씬

Search-only metadata; an alias is not proof of chemical equivalence.

Functions listed by CosIng

SKIN CONDITIONING

Inventory functions describe the ingredient entry, not a finished product’s effects.

How this inventory match is used

The European Commission’s CosIng inventory is informational. An entry is not permission to use an ingredient or a safety assessment. Listed functions describe the inventory entry; they do not establish a finished product’s effects. The match uses the exact ingredient name, with case and whitespace normalization.

ADENOSINE · Inventory identifiers

Inventory record: 31367 · Active
CAS identifiers in this entry: 58-61-7
EC identifiers in this entry: 200-389-9

Checked 2026-10-02 · Read the official CosIng entry

Human study context

Primary publications checked 2026-10-03. These are selected studies, not a systematic review, safety rating or instructions for using a product.

Evaluation of anti-wrinkle efficacy of adenosine-containing products using the FOITS technique.

2006 · Original abstract reviewed

Material tested: Adenosine-containing cream or dissolvable film versus placebo; concentration absent from the abstract.
Study design: Blind, randomized, placebo-controlled study; paired facial areas.
Participants: 126 women aged 45–65; 84 per product, with 84 also eligible for glabellar assessment.
Concentration and schedule in the study: Twice daily for two months; assessments at baseline, three and eight weeks.
What the authors reported: Authors reported smoother periorbital profiles with both active formats and improved glabellar frowns with the cream.

What this does not establish

The abstract does not disclose concentration or exact effect sizes.
Optical surface measurements do not establish collagen production or equivalent finished-product outcomes. Publication year 2006, not the later indexing date.

Read the original publication

Still unverified

Selected primary abstracts only, not a systematic review or a complete scientific profile.
Test preparations have not been matched to any Treatfolio product, market, batch or package.
Study schedules are not consumer instructions; regulatory status and personal suitability require separate evidence.
Chemical identity, the complete current regulatory profile and finished-product effects remain unverified.